Xiao‐Peng Tian

1.3k total citations · 1 hit paper
41 papers, 654 citations indexed

About

Xiao‐Peng Tian is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xiao‐Peng Tian has authored 41 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Xiao‐Peng Tian's work include Lymphoma Diagnosis and Treatment (17 papers), T-cell and Retrovirus Studies (5 papers) and CAR-T cell therapy research (5 papers). Xiao‐Peng Tian is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), T-cell and Retrovirus Studies (5 papers) and CAR-T cell therapy research (5 papers). Xiao‐Peng Tian collaborates with scholars based in China, Hong Kong and United States. Xiao‐Peng Tian's co-authors include Song‐Bin Guo, Weijuan Huang, Qingqing Cai, Jun Cai, Yan Qin, Zhibin Huo, Shu‐Yun Ma, Hailong Li, Jing‐Kai Huang and Meng Yuan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xiao‐Peng Tian

39 papers receiving 652 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation

2024 60 citations Song‐Bin Guo, Meng Yuan et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiao‐Peng Tian China	16	287	220	171	127	101	41	654
Yanfeng Xi China	16	269 0.9×	276 1.3×	185 1.1×	114 0.9×	133 1.3×	78	713
Xiaolong Wu China	14	317 1.1×	241 1.1×	231 1.4×	127 1.0×	87 0.9×	70	723
Yuting Yi China	14	252 0.9×	155 0.7×	192 1.1×	97 0.8×	52 0.5×	54	631
Tingting Zhao China	17	278 1.0×	177 0.8×	224 1.3×	113 0.9×	64 0.6×	35	672
Qiang Zuo China	13	417 1.5×	315 1.4×	200 1.2×	100 0.8×	79 0.8×	39	805
Xiaoqin Yang China	14	227 0.8×	310 1.4×	143 0.8×	59 0.5×	157 1.6×	29	633
Ji Hun Kim South Korea	15	337 1.2×	251 1.1×	135 0.8×	93 0.7×	58 0.6×	25	629
Andrea Pretta Italy	12	182 0.6×	272 1.2×	139 0.8×	59 0.5×	59 0.6×	47	478
Junji Yamashita Japan	17	473 1.6×	164 0.7×	241 1.4×	113 0.9×	195 1.9×	40	886

Countries citing papers authored by Xiao‐Peng Tian

Since Specialization

Citations

This map shows the geographic impact of Xiao‐Peng Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Peng Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Peng Tian more than expected).

Fields of papers citing papers by Xiao‐Peng Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Peng Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Peng Tian. The network helps show where Xiao‐Peng Tian may publish in the future.

Co-authorship network of co-authors of Xiao‐Peng Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Peng Tian. A scholar is included among the top collaborators of Xiao‐Peng Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Peng Tian. Xiao‐Peng Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Zhiwei, Jiabin Lu, Song‐Bin Guo, et al.. (2025). A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features. Cancer Medicine. 14(2). e70602–e70602. 3 indexed citations

Guo, Song‐Bin, et al.. (2024). Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation. Molecular Cancer. 23(1). 223–223. 60 indexed citations breakdown →

He, Jiajun, Kunhao Bai, Ruonan Shao, et al.. (2024). Tigecycline-induced coagulation gene prognostic prediction model and intestinal flora signature in AML. Frontiers in Immunology. 15. 1486592–1486592. 1 indexed citations

Su, Ning, Yi Cao, Yi Xia, et al.. (2023). Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial. BMC Medicine. 21(1). 423–423. 8 indexed citations

Tian, Xiao‐Peng, Yi Cao, Jun Cai, et al.. (2023). Novel target and treatment agents for natural killer/T-cell lymphoma. Journal of Hematology & Oncology. 16(1). 78–78. 9 indexed citations

Jiang, Lijuan, et al.. (2023). PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Pathology - Research and Practice. 247. 154536–154536. 14 indexed citations

Guo, Song‐Bin, et al.. (2023). Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures. Frontiers in Endocrinology. 14. 1266721–1266721. 14 indexed citations

Huang, Weijuan, Song‐Bin Guo, Hui Shi, et al.. (2023). The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance. Journal of Experimental & Clinical Cancer Research. 42(1). 105–105. 18 indexed citations

Guo, Song‐Bin, et al.. (2023). A scientometrics and visualization analysis of oxidative stress modulator Nrf2 in cancer profiles its characteristics and reveals its association with immune response. Heliyon. 9(6). e17075–e17075. 26 indexed citations

10.

Su, Ning, Fang Yu, Shu‐Yun Ma, et al.. (2022). Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma. Frontiers in Immunology. 13. 835103–835103. 13 indexed citations

11.

Yu, Fang, Ning Su, Shu‐Yun Ma, et al.. (2022). Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis. Annals of Hematology. 101(3). 595–605. 3 indexed citations

12.

Cai, Jun, Xiao‐Peng Tian, Shu‐Yun Ma, et al.. (2021). A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study. British Journal of Cancer. 125(3). 402–412. 11 indexed citations

13.

Yu, Fang, Shu‐Yun Ma, Ning Su, et al.. (2021). Comparison of chidamide-contained treatment modalities versus chemotherapy in the second-line treatment for relapsed or refractory peripheral T-cell lymphoma. Leukemia Research. 111. 106705–106705. 6 indexed citations

14.

Ma, Shu‐Yun, Xiao‐Peng Tian, Jun Cai, et al.. (2021). A prognostic immune risk score for diffuse large B‐cell lymphoma. British Journal of Haematology. 194(1). 111–119. 12 indexed citations

15.

Tian, Xiao‐Peng, Jun Cai, Shu‐Yun Ma, et al.. (2020). BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma. Cancer Communications. 40(6). 245–259. 19 indexed citations

16.

Huang, Weijuan, Xiao‐Peng Tian, Sixue Bi, et al.. (2020). The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis. Oncogene. 39(23). 4538–4550. 54 indexed citations

17.

Tian, Xiao‐Peng, Juntao Wang, Xianhao Liu, et al.. (2018). Treatment of metastatic non‑small cell lung cancer with NY‑ESO‑1 specific TCR engineered‑T cells in a phase I clinical trial: A case report. Oncology Letters. 16(6). 6998–7007. 40 indexed citations

18.

Huang, Jing‐Kai, et al.. (2014). Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor-β/Smad pathway in rats. Molecular Medicine Reports. 11(2). 805–814. 22 indexed citations

19.

Huang, Jing‐Kai, et al.. (2014). Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/smad pathway. Molecular Medicine Reports. 11(4). 2569–2577. 5 indexed citations

20.

Zhang, Xintao, et al.. (2014). Roles of TGF-β/Smad signaling pathway in pathogenesis and development of gluteal muscle contracture. Connective Tissue Research. 56(1). 9–17. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact